ArticleMedical sciences (Basel, Switzerland)2026
Real-World Clinical Outcomes of Azacitidine Versus Best Supportive Care in Higher-Risk Myelodysplastic Neoplasms: A Single-Center Cohort Study.
Mihai-Emilian Lapadat et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.